Pharmacists and wholesalers shun returning old OTC-version Diane 35, Schering Korea says

Published: 2007-10-29 06:57:00

Updated: 2007-10-29 06:57:00

Schering Korea is troubled by recovering the old stocks of Diane 35 that are shunned by pharmacists and wholesalers who desire to boost their sluggish sales.

Diane 35 was approved by the Korea Food and Drug Administration as an OTC product. It is a hormonal contraceptive tablet that is prescri...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK